Uptake and associated factors of the second dose of measles–rubella vaccine among children aged 18–23 months in Uganda, August-September 2024
A 2024 cross-sectional survey in Uganda reveals that the national coverage of the second dose of the measles–rubella vaccine remains critically low at 32.0%, driven by significant regional disparities and influenced by factors such as birth order, household composition, age, and caregiver experiences with vaccine safety and service quality.
Original paper licensed under CC BY 4.0 (https://creativecommons.org/licenses/by/4.0/). This is an AI-generated explanation of the paper below. It is not written or endorsed by the authors. For technical accuracy, refer to the original paper. Read full disclaimer
Imagine Uganda's immunization program as a massive, well-oiled race. The first lap, where babies get their first shot against measles and rubella (MR1), is a sprint they are crushing. In 2023, a whopping 93% of babies crossed that finish line. But then, the race hits a strange, bumpy patch for the second lap. This is the MR2 shot, meant for toddlers aged 18 to 23 months. While the first lap was a victory, the second lap has stalled.
In August and September 2024, researchers went door-to-door across Uganda to see what happened to the toddlers. They found that only 32.0% of children in this age group had actually received their second dose. That's like a relay team where almost everyone runs the first leg, but only one in three makes it to the second baton handoff. The goal for stopping these diseases is 95%, so the country is still running a long way behind the finish line.
The researchers didn't just count the runners; they looked at why some families stopped at the first leg while others kept going. They used a special map called the "BeSD framework" to track the behavioral and social drivers, kind of like checking the weather, the terrain, and the team morale before a race.
Here is what the data revealed about the obstacles on the track:
The "First Born" Advantage
It turns out, being the first child in the family gives you a head start. First-born children were 1.71 times more likely to get their second shot compared to children born fourth or later. Think of it like a new video game: parents are super careful and follow the "instruction manual" perfectly for the first character, but as the family grows and life gets busier, the rules might get a little looser for the later players. Interestingly, children born second or third also did better than those born fourth or higher, but the biggest gap was between the very first child and the larger families.
The "Two-for-One" Boost
Interestingly, families with two or more eligible children at the time of the survey were 2.42 times more likely to get the vaccine than families with just one. It's as if having more kids in the house creates a "group trip" vibe to the clinic, making it easier to remember to go, whereas a single child might get missed in the shuffle of daily life.
The Age Factor
Every single month a child gets older, their chances of getting the shot go up by about 9%. It's a slow climb, but it suggests that as toddlers get closer to their second birthday, parents are more likely to finally get them to the clinic.
The "Scary Story" and the "Bad Service" Barriers
Two big things were stopping families from finishing the race:
- Fear of Side Effects: If a caregiver remembered a child having a bad reaction to a previous vaccine (an Adverse Event Following Immunization, or AEFI), they were 0.41 times as likely to bring the child back for the second dose. It's like getting a flat tire on a bike; if the ride was scary once, the parent might be too afraid to try the second leg of the journey.
- Bad Experiences: If a parent was unhappy with how they were treated at the clinic—maybe long waits, rude staff, or empty shelves—they were only 0.18 times as likely to return. A bad service experience is like a pothole that breaks your wheel; it doesn't just slow you down, it stops you from coming back at all.
Regional Speed Bumps
The race wasn't the same everywhere. In the Northern region, 41.4% of kids got the shot, which is the best performance. But in the Eastern region, only 22.0% got it. The Western and Central regions were somewhere in the middle, at 34.5% and 27.6% respectively. This shows that the problem isn't just one thing; it's a mix of local challenges in different parts of the country.
A Surprising Twist
The study also found something that might seem odd at first glance: children with female primary caregivers were significantly less likely to be vaccinated than those with male caregivers (about 0.59 times as likely). However, the researchers are very careful here. Since only 6.4% of the caregivers in their study were men, this might just be a fluke of the small group they looked at, rather than a rule for the whole country. It's like seeing a small sample of a race where the few men running happened to be faster, but we can't say for sure that men are generally faster runners without more data.
What This Means for the Future
The paper doesn't claim to have solved the mystery yet. Instead, it suggests that to get more kids to the finish line, Uganda needs to fix the "pit stops." This means making sure clinics are friendly and have vaccines in stock, talking openly about what happens after a shot so parents aren't scared, and finding ways to remind families to bring their toddlers back for the second lap.
The authors measured these numbers carefully using a rigorous survey of 750 children across 15 districts, but they admit there are limits. They couldn't interview families who didn't have vaccination cards, which means the real number of unvaccinated kids might be even lower than 32.0%. They also can't prove why these things happened just from this one snapshot in time; they can only say that these factors are strongly linked.
In short, the second dose of the measles-rubella vaccine in Uganda is currently stuck in traffic. The road is there, but the drivers need better maps, fewer potholes, and a lot more encouragement to get the whole team across the finish line.
Drowning in papers in your field?
Get daily digests of the most novel papers matching your research keywords — with technical summaries, in your language.